Source: Eur Respir Monogr 2022; 96: 107-121



Rating:

Share or cite this content

Citations should be made in the following way:
Ingrid H.E. Korenromp, Lisa A. Maier, Jan C. Grutters. Sarcoidosis: serum and imaging biomarkers. Eur Respir Monogr 2022; 96: 107-121

Member's Comments

No comment yet.

Related content which might interest you: The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis? Source: International Congress 2017 – Rare diseases Year: 2017 Diagnostic and prognostic value of advanced imaging modalities in patients with suspected cardiac sarcoidosis Source: International Congress 2016 – Sarcoidosis Year: 2016 The effect of exercise on serum amyloid a levels in patients with sarcoidosis: A preliminary report Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 MR imaging of lung parenchymal changes in sarcoidosis Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 Correlation of 18F-FDG PET/CT with inflammatory biomarkers in sarcoidosis Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Comparative role of serum cathepsin S concentrations for differential diagnosis of sarcoidosis from other lung diseases Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Value of MR imaging in the early detection of cardiac involvement in sarcoidosis Source: Annual Congress 2006 - New modalities and application in imaging of the chest Year: 2006 Non-invasive diagnosis of lymphangioleiomyomatosis: new biomarkers Source: International Congress 2018 – Russian Speaking Programme 2018: Part II Year: 2018 Biomarkers of Sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme and KL-6 Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues Year: 2019 Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease? Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006 Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay. Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Long-term results obtained by cardiovascular magnetic resonance imaging and somatostatin receptor PET in cardiac sarcoidosis Source: International Congress 2016 – Mixed-up imaging of various chest diseases Year: 2016 The utility of cardiac magnetic resonance imaging in the diagnosis of cardiac sarcoidosis Source: International Congress 2014 – The MRI modality becomes clinically mature: lung MRI Year: 2014 Novel imaging biomarkers for assessment of lung fibrosis and inflammation Source: Virtual Congress 2021 – Emerging imaging biomarkers in lung disease Year: 2021 Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis? Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004 Sarcoidosis: conventional and nuclear imaging techniques Source: Eur Respir Monogr 2022; 96: 75-90 Year: 2022 Serum amyloid A as a potential biomarker of sarcoidosis Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 18F-FDG-PET/CT for the evaluation of sarcoidosis patients Source: International Congress 2014 – Different modalities and techniques for lung imaging Year: 2014